Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ARDX · against 486 other Healthcare companies of similar size
Ranked #324 of 487 · scores higher than 11% of peers
Bars: peers in each 10-point band of the valuation score164 peers with a valuation score of 0–9, including ARDX · Click a bar to see the companies
Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.
| Metric | ARDX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 475 reported | -7.6% | 1.1% | 23% | 30% | |
| EBITDA yieldHigher is better · 493 reported | -4.3% | 3.9% | 22% | 50% | |
| Free cash flow yieldHigher is better · 201 reported | -2.3% | -3.1% | 54% | 20% | |
| Book yieldHigher is better · 484 reported | 19.7% | 43.8% | 19% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 6.50T IDR (≈$403M) | 99 | 69 | |
| 324 | 397M USD | 8 | 37 | |
| 324 | 794M USD | 8 | ||
| 324 | 891M USD | 8 | ||
| 324 | 487M USD | 8 | 24 | |
| 324 | 782M USD | 8 | 35 | |
| 324 | 647M USD | 8 | 40 | |
| 324 | 546M USD | 8 | 31 | |
| 324 | 815M USD | 8 | 53 | |
| 324 | 593M USD | 8 | 40 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score